RT Journal Article
SR Electronic
T1 Shift work is associated with positive COVID-19 status in hospitalised patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.04.20244020
DO 10.1101/2020.12.04.20244020
A1 Maidstone, Robert
A1 Anderson, Simon G
A1 Ray, David W
A1 Rutter, Martin K
A1 Durrington, Hannah J
A1 Blaikley, John F
YR 2020
UL http://medrxiv.org/content/early/2020/12/07/2020.12.04.20244020.abstract
AB Introduction Shift work is associated with both mental, and physical ill health, including lung disease and infections. However, the impact of shift work on significant COVID-19 illness has not be assessed. We therefore investigated whether shift work is associated with COVID-19.Methods 501,000 UK biobank participants were linked to secondary care SARS-CoV-2 PCR results from public health England. Healthcare workers and those without an occupational history were excluded from analysis.Results Multivariate logistic regression taking into account age, sex, ethnicity and deprivation index revealed that irregular shift work (OR 2.42 95%CI 1.92-3.05), permanent shift work (OR 2.5, 95%CI 1.95-3.19), day shift work (OR 2.01, 95%CI 1.55-2.6), irregular night shift work (OR 3.04, 95%CI 2.37-3.9) and permanent night shift work (OR 2.49, 95%CI 1.67-3.7) were all associated with positive COVID-19 tests compared to participants that did not perform shift work. This relationship persisted after adding sleep duration, chronotype, pre-morbid disease, BMI, alcohol and smoking. Work factors (proximity to a colleague combined with estimated disease exposure) were positively correlated with COVID-19 incidence (r2=0.248, p=0.02). If this was added to the model shift work frequency remained significantly associated with COVID-19. To control for non-measured occupational factors the incidence of COVID-19 in shift workers was compared to colleagues in the same job who did not do shift work. Shift workers had a higher incidence of COVID-19 (p<0.01).Conclusions Shift work is associated with a higher likelihood of in-hospital COVID-19 positivity. This risk could potentially be mitigated via additional workplace precautions or vaccination.Competing Interest StatementMR has received speaker fees and research support from Novo Nordisk and Roche Diabetes Care for research unrelated to that presented here.Funding StatementThis research was funded by the NIHR Manchester Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. RJM is funded by (MR/P023576/1) and DWRs Wellcome trust Investigator award (107849/Z/15/Z). HJD holds a Deans Clinical Prize from the University of Manchester and receives funding from the Moulton Charitable Trust and the North West Lung Charity. JFB is a MRC transition support fellow (MR/T032529/1). DWR is supported by a Wellcome investigator, and NIHR Oxford Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR, or Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:National Health Service National Research Ethics Service (ref. 11/NW/0382) HTA (IRAS 282966)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon reasonable request when the study has been formally published.